Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of May 21, 2026, AXGN trades at $42.94 with a market cap of $2.23B and a P/E ratio of -67.85. AXGN moved -0.07% today. Year to date, AXGN is +34.41%; over the trailing twelve months it is +268.97%. Its 52-week range spans $9.22 to $45.83. Analyst consensus is strong buy with an average price target of $50.14. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes AXGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $42.94 |
| Market Cap | $2.23B |
| P/E Ratio | -67.85 |
| EPS | $-0.63 |
| Dividend Yield | 1.00% |
| 52-Week High | $45.83 |
| 52-Week Low | $9.22 |
| Volume | 32 |
| Avg Volume | 0 |
| Revenue (TTM) | $238.10M |
| Net Income | $-31.45M |
| Gross Margin | 75.01% |
7 analysts cover AXGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.14.